TCI Wealth Advisors’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-594	Closed	-$5.99K	–	2556
2022 Q4	$5.99K	Buy	594 +225	+61%	+$4.23K	﹤0.01%	1403
2022 Q3	$8K	Buy	369 +87	+31%	+$2.51K	﹤0.01%	1146
2022 Q2	$7K	Buy	282 +132	+88%	+$3.64K	﹤0.01%	1235
2022 Q1	$6K	Sell	150 -255	-63%	-$9.87K	﹤0.01%	1411
2021 Q4	$24K	Buy	405 +61	+18%	+$3.46K	﹤0.01%	627
2021 Q3	$20K	Buy	344 +86	+33%	+$6.75K	﹤0.01%	692
2021 Q2	$22K	Sell	258 -315	-55%	-$25.4K	﹤0.01%	586
2021 Q1	$47K	Buy	573 +73	+15%	+$7K	0.02%	363
2020 Q4	$45K	Sell	500 -300	-38%	-$18.6K	0.02%	351
2020 Q3	$32K	Sell	800 -25	-3%	-$873	0.01%	374
2020 Q2	$28K	Hold	825	–	–	0.01%	390
2020 Q1	$18K	Sell	825 -100	-11%	-$2.53K	0.01%	462
2019 Q4	$18K	Sell	925 -400	-30%	-$6.35K	0.01%	568
2019 Q3	$21K	Sell	1,325 -100	-7%	-$1.92K	0.01%	482
2019 Q2	$29K	Hold	1,425	–	–	0.01%	404
2019 Q1	$25K	Sell	1,425 -300	-17%	-$4.74K	0.01%	450
2018 Q4	$22K	Buy	1,725 +100	+6%	+$1.39K	0.01%	455
2018 Q3	$26K	Sell	1,625 -100	-6%	-$1.18K	0.01%	446
2018 Q2	$20K	Buy	1,725 +100	+6%	+$1.1K	0.01%	481
2018 Q1	$16K	Buy	1,625 +100	+7%	+$958	0.01%	526
2017 Q4	$9K	Sell	1,525 -75	-5%	-$335	﹤0.01%	654
2017 Q3	$6K	Buy	1,600 +800	+100%	+$2.72K	﹤0.01%	695
2017 Q2	$3K	Buy	800 +300	+60%	+$1.15K	﹤0.01%	869
2017 Q1	$2K	Hold	500	–	–	﹤0.01%	929
2016 Q4	$1K	Buy	+500	New	+$1.34K	﹤0.01%	1153

Other funds holding FATE